Research Topics
| Giovanni La MontagnaSummaryAffiliation: Second University of Naples Country: Italy Publications
| Collaborators
|
Detail Information
Publications
High prevalence of metabolic syndrome in patients with ankylosing spondylitisDomenico Malesci
Unita di Reumatologia, Seconda Universita di Napoli, Policlinico Via Pansini 5, 80131 Naples, Italy
Clin Rheumatol 26:710-4. 2007..This preliminary report points out a higher prevalence of MetS in AS pts than in controls. Further studies are needed to confirm this finding...
Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disabilityMaurizio Rossini
Rheumatology Unit, University of Verona, Piazzale Stefani 1, 37124 Verona, Italy
Arthritis Res Ther 12:R216. 2010....
Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritisGiovanni La Montagna
Department of Clinical and Experimental Medicine and Surgery Rheumatology Unit, Second University of Naples, Via Pansini, 5 80131 Naples, Italy
Diab Vasc Dis Res 4:130-5. 2007..This relationship may be driven primarily by exposure to steroid therapy...
[Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice]G La Montagna
Unita di Reumatologia, Seconda Universita degli Studi di Napoli, Italia
Reumatismo 58:261-7. 2006..To evaluate the treatment duration with MTX monotherapy or in association with DMARDs or TNFalpha inhibitors and the incidence and typology of adverse events (AE) occurred in rheumatoid arthritis (RA) patients...
The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging studyGiovanni La Montagna
Dipartimento Medico Chirurgico di Internistica, Clinica e Sperimentale F Magrassi e A Lanzara, Unità Operativa di Reumatologia, Seconda Universita di Napoli, 80131 Naples, Italy
Skeletal Radiol 34:35-41. 2005..To assess the clinical and radiological features of systemic sclerosis (SSc) joint involvement in a prospective cross-sectional study...
Successful neridronate therapy in transient osteoporosis of the hipGiovanni La Montagna
Dipartimento Medico Chirurgico di Internistica Clinica e Sperimentale F Magrassi and A Lanzara, Seconda Universita degli Studi di Napoli, Napoli, Italy
Clin Rheumatol 24:67-9. 2005..The clinical features and the therapeutic action of intramuscular neridronate sodium, a third-generation amino-bisphosphonate, are underlined...
Bioactivity of prolactin in systemic sclerosisG La Montagna
Dipartimento Scientifico di Internistica Clinica e Sperimentale F Magrassi and A Lanzara, Seconda Universita di Napoli, Naples, Italy
Clin Exp Rheumatol 22:145-50. 2004..To evaluate basal serum prolactin (PRL) levels in systemic sclerosis (SSc) patients with different degrees of skin involvement, and investigate its relationship with some of the clinical and serological parameters of the disease...
Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of diseaseGiovanni La Montagna
Dipartimento Medico Chirurgico di Internistica Clinica e Sperimentale F Magrassi e A Lanzara, Unità Operativa di Reumatologia, Seconda Universita di Napoli, Policlinico Via S Pansini 5, 80131 Naples, Italy
J Rheumatol 30:2147-51. 2003..To investigate the behavior of serum YKL-40 in a cohort of patients with systemic sclerosis (SSc)...
Foot involvement in systemic sclerosis: a longitudinal study of 100 patientsGiovanni La Montagna
Dipartimento di Internistica Clinica e Sperimentale F Magrassi Seconda Università degli Studi di Napoli, Naples, Italy
Semin Arthritis Rheum 31:248-55. 2002..To investigate the clinical and radiologic features of foot involvement in systemic sclerosis (SSc)...
[A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens]Giovanna Cuomo
Unità Operativa di Reumatologia, Seconda Universita di Napoli, Napoli
Reumatismo 58:22-5. 2006..To compare the SDAI values to DAS28 scores in RA patients undergoing different DMARD regimens...
Low-dose intravenous cyclophosphamide in systemic sclerosis: a preliminary safety studyGiovanna Cuomo
Rheumatology Unit, Department of Clinical and Experimental Medicine, Second University of Naples, Edificio 3, Via Pansini 5, 80131 Naples, Italy
Clin Rheumatol 22:393-6. 2003..Our data suggest that low-dose intravenous CYC is relatively safe, at least in the short term. Further studies are needed to assess both the efficacy and the long-term safety...
Echocardiographic alterations in systemic sclerosis: a longitudinal studyStefania Maione
Department of Clinical Medicine, Cardiovascular and Immunological Science, University of Naples Federico II, Italy
Semin Arthritis Rheum 34:721-7. 2005..To investigate the evolution of cardiac alterations in systemic sclerosis (SSc)...
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patientsClodoveo Ferri
Rheumatology Unit, Department of Internal Medicine, University of Pisa, Italy
Medicine (Baltimore) 81:139-53. 2002
